Back
HCV Treatment 
Approved HCV Drugs
Approved HCV Drugs
Approved HCV Drugs
Telaprevir (Incivek) Approved for Hepatitis C
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 24 May 2011 14:19
- Written by Liz Highleyman
Boceprevir (Victrelis) Approved for Hepatitis C
- Details
- Category: Approved HCV Drugs
- Published on Monday, 16 May 2011 17:02
- Written by Liz Highleyman
Boceprevir for HCV Wins Unanimous FDA Committee Recommendation
- Details
- Category: Approved HCV Drugs
- Published on Friday, 29 April 2011 14:41
- Written by Liz Highleyman
FDA Antiviral Drugs Advisory Committee voted 18-0 to recommend approval of protease inhibitor boceprevir (Victrelis) for people with hard-to-treat HCV genotype 1.
FDA Committee Unanimously Recommends Telaprevir (Incivek)
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 03 May 2011 16:14
- Written by Liz Highleyman
The FDA Antiviral Drugs Advisory Committee last week voted 18-0 to recommend approval of the HCV protease inhibitor telaprevir (Incivek) for people with genotype 1 chronic hepatitis C.
EASL 2011: Telaprevir Improves HCV Cure Rates Regardless of IL28B Status
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 05 April 2011 06:57
- Written by Vertex Pharmaceuticals
The Vertex experimental protease inhibitor telaprevir, taken with pegylated interferon plus ribavirin, increased sustained response in people with all IL28B gene patterns, researchers reported at EASL 2011.
More Articles...
- Boceprevir Improves Response to Interferon-Based HCV Therapy
- CROI 2011: Interactions of HIV Meds with HCV drugs Telaprevir and Boceprevir
- DDW 2008: Pegylated Interferon (Pegasys) Continues to Suppress HBV, Adding Adefovir (Hepsera) Provides No Extra Benefit
- Can Chronic Hepatitis C Patients with Genotypes 2 or 3 Benefit from Shorter Interferon Treatment?
Web Design and Development by